22q11.2 Deletion Syndrome (22q11DS) is neuro-genetic disorder that predisposes individuals to increased risk for of
multiple form of psychopathology and schizophrenia in particular. Indeed, up to 40% of individuals with 22q11DS
will develop schizophrenia by adulthood. Since 2001 the DIPLab has performed longitudinal follow-up in one of the
largest cohorts of children and adolescents with 22q11DS. Our comprehensive research protocol consists in gold-
standard neuroimaging acquisitions, including structural MRI, functional MRI and diffusion-weighted MRI as well as
high-density EEG. Moreover, we perform extensive neuro-cognitive and clinical evaluations. Our aim is to understand
how atypical maturation of the brain contributes to vulnerability to schizophrenia, to both characterize relevant
neurodevelopmental mechanisms and to detect early biomarkers of vulnerability to the disorder
More: https://wp.unil.ch/lemanicneuroscience/files/2024/06/Open-position_DIPLAB.pdf